Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]

Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC] was reported 540 times

Drugs of the Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SOMATIC PAIN 1 0.2000
1 BLOOD HIV RNA 4 0.0769
2 CONGENITAL HIV INFECTION 2 0.0513
3 ANAL CANCER RECURRENT 1 0.0476
4 VULVAL CANCER STAGE 0 1 0.0179
5 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 11 0.0126
6 T-LYMPHOCYTE COUNT DECREASED 8 0.0117
7 VIRAL LOAD INCREASED 45 0.0116
8 GENOTYPE DRUG RESISTANCE TEST POSITIVE 11 0.0107
9 MIDDLE CEREBRAL ARTERY STROKE 1 0.0088
10 INJECTION SITE DERMATITIS 1 0.0069
11 INFUSION SITE INJURY 1 0.0057
12 T-LYMPHOCYTE COUNT INCREASED 1 0.0054
13 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0045
14 BLOOD HIV RNA INCREASED 8 0.0044
15 CD4 LYMPHOCYTES INCREASED 1 0.0043
16 CHRONIC DISEASE 1 0.0039
17 VIROLOGIC FAILURE 18 0.0033
18 GASTROENTERITIS ROTAVIRUS 1 0.0032
19 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
20 ALLERGY TO ARTHROPOD BITE 1 0.0031
21 NEONATAL INFECTION 1 0.0029
22 EOSINOPHILIC FASCIITIS 1 0.0029
23 CD4 LYMPHOCYTES DECREASED 6 0.0028
24 CONVULSIVE THRESHOLD LOWERED 1 0.0025
25 UTERINE MASS 1 0.0024
26 PERITONEAL DIALYSIS 2 0.0024
27 REFLUX LARYNGITIS 1 0.0023
28 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 11 0.0022
29 VIRAL MUTATION IDENTIFIED 8 0.0022
30 VIRAEMIA 3 0.0022
31 TOBACCO ABUSE 1 0.0019
32 GROIN INFECTION 1 0.0018
33 INFUSION SITE RASH 2 0.0015
34 PATHOGEN RESISTANCE 13 0.0014
35 MUSCLE DISCOMFORT 1 0.0013
36 STOMACH MASS 1 0.0013
37 PENILE HAEMORRHAGE 1 0.0012
38 VEIN RUPTURE 2 0.0012
39 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
40 OPPORTUNISTIC INFECTION 2 0.0011
41 BIOPSY 1 0.0011
42 OVARIAN DISORDER 1 0.0011
43 IDIOSYNCRATIC DRUG REACTION 1 0.0010
44 CORONAVIRUS TEST POSITIVE 1 0.0010
45 INFUSION SITE DISCOMFORT 1 0.0010
46 HEPATITIS B REACTIVATION 3 0.0009
47 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
48 PNEUMONIA INFLUENZAL 1 0.0008
49 PHARYNGEAL HAEMORRHAGE 1 0.0008
50 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
51 ADJUSTMENT DISORDER 1 0.0008
52 HEPATITIS TOXIC 2 0.0008
53 PROSTATE CANCER STAGE III 2 0.0008
54 SKIN DEPIGMENTATION 1 0.0007
55 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
56 MYELITIS TRANSVERSE 1 0.0007
57 ORAL MUCOSAL ERUPTION 1 0.0007
58 INJECTION SITE INFECTION 2 0.0006
59 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
60 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
61 SALMONELLOSIS 1 0.0006
62 OTORRHOEA 1 0.0006
63 TUNNEL VISION 1 0.0005
64 ALCOHOL INTERACTION 1 0.0005
65 COLOSTOMY 1 0.0005
66 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
67 ANORECTAL DISORDER 1 0.0005
68 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
69 EAR SWELLING 1 0.0005
70 TENSION HEADACHE 2 0.0005
71 BRADYPHRENIA 3 0.0005
72 CERVICAL DYSPLASIA 1 0.0005
73 ORAL SURGERY 1 0.0004
74 DRUG RESISTANCE 10 0.0004
75 FAILURE TO THRIVE 2 0.0004
76 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
77 URINE OUTPUT INCREASED 1 0.0004
78 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
79 BLOOD SODIUM INCREASED 1 0.0004
80 ELECTRIC SHOCK SENSATION 1 0.0004
81 PNEUMATOSIS INTESTINALIS 1 0.0004
82 SKIN WARM 2 0.0003
83 PULMONARY PAIN 1 0.0003
84 CENTRAL VENOUS CATHETERISATION 1 0.0003
85 EMERGENCY CARE 1 0.0003
86 INFUSION SITE EXTRAVASATION 2 0.0003
87 INJECTION SITE HYPERSENSITIVITY 1 0.0003
88 NON-CARDIAC CHEST PAIN 1 0.0003
89 VITREOUS FLOATERS 3 0.0003
90 PRODUCT PREPARATION ISSUE 2 0.0003
91 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
92 B-CELL LYMPHOMA 1 0.0003
93 PARANASAL SINUS DISCOMFORT 1 0.0003
94 OESOPHAGEAL PAIN 1 0.0003
95 DEMYELINATION 1 0.0002
96 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
97 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
98 UTERINE HAEMORRHAGE 1 0.0002
99 HOSPITALISATION 36 0.0002
100 PURULENT DISCHARGE 1 0.0002
101 BLOOD MAGNESIUM DECREASED 2 0.0002
102 NODULE 3 0.0002
103 IMMOBILE 1 0.0002
104 ABDOMINAL ABSCESS 1 0.0002
105 BLOOD CREATINE INCREASED 1 0.0002
106 MYOSITIS 2 0.0002
107 INTERCEPTED MEDICATION ERROR 1 0.0002
108 TIBIA FRACTURE 1 0.0002
109 RASH VESICULAR 1 0.0002
110 LYMPHOMA 3 0.0002
111 TREATMENT NONCOMPLIANCE 10 0.0002
112 INJECTION SITE NODULE 2 0.0002
113 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
114 EYE INFECTION 2 0.0002
115 HERPES VIRUS INFECTION 1 0.0002
116 METABOLIC DISORDER 1 0.0002
117 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
118 PRODUCT DOSE OMISSION 11 0.0002
119 WRIST FRACTURE 2 0.0002
120 RASH PRURITIC 9 0.0002
121 MENISCUS INJURY 1 0.0002
122 LARYNGEAL OEDEMA 1 0.0002
123 PIGMENTATION DISORDER 1 0.0002
124 SWELLING OF EYELID 1 0.0002
125 PHOTOPSIA 1 0.0002
126 PROCTALGIA 1 0.0002
127 PRODUCT DOSE OMISSION ISSUE 45 0.0002
128 ORAL CANDIDIASIS 2 0.0002
129 SKIN MASS 1 0.0001
130 WRONG PRODUCT ADMINISTERED 1 0.0001
131 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
132 PAPULE 1 0.0001
133 HAND FRACTURE 1 0.0001
134 TONGUE DISORDER 1 0.0001
135 ORAL DISORDER 1 0.0001
136 SENSITIVE SKIN 1 0.0001
137 EYE SWELLING 5 0.0001
138 THERAPY NON-RESPONDER 6 0.0001
139 OSTEOPENIA 2 0.0001
140 BOWEL MOVEMENT IRREGULARITY 1 0.0001
141 FOOD ALLERGY 1 0.0001
142 UTERINE CANCER 1 0.0001
143 POLYURIA 1 0.0001
144 HICCUPS 1 0.0001
145 EOSINOPHIL COUNT INCREASED 1 0.0001
146 CANDIDA INFECTION 2 0.0001
147 FACIAL PARALYSIS 1 0.0001
148 SCAR 2 0.0001
149 CARDIAC OPERATION 1 0.0001
150 MUSCLE STRAIN 1 0.0001
151 ANHEDONIA 3 0.0001
152 TUMOUR LYSIS SYNDROME 1 0.0001
153 HEAD DISCOMFORT 2 0.0001
154 ISCHAEMIC STROKE 2 0.0001
155 PNEUMONIA BACTERIAL 1 0.0001
156 RETINAL DETACHMENT 1 0.0001
157 INJECTION SITE MASS 4 0.0001
158 APPENDICITIS 1 0.0001
159 SPUTUM DISCOLOURED 1 0.0001
160 PHARYNGEAL SWELLING 1 0.0001
161 THERAPY CHANGE 1 0.0001
162 HOSPICE CARE 1 0.0001
163 RASH 43 0.0001
164 TOOTH ABSCESS 1 0.0001
165 PRODUCT PREPARATION ERROR 2 0.0001
166 TREATMENT FAILURE 8 0.0001
167 SWOLLEN TONGUE 3 0.0001
168 INJECTION SITE DISCOMFORT 1 0.0001
169 SUDDEN DEATH 1 0.0001
170 LIVER FUNCTION TEST INCREASED 2 0.0001
171 OESOPHAGITIS 1 0.0001
172 MALNUTRITION 1 0.0001
173 RASH PAPULAR 2 0.0001
174 OCULAR DISCOMFORT 1 0.0001
175 PANCREATITIS ACUTE 2 0.0001
176 SCAB 1 0.0001
177 TINNITUS 4 0.0001
178 SKIN DISCOLOURATION 4 0.0001
179 ELECTROLYTE IMBALANCE 1 0.0001
180 SPINAL PAIN 1 0.0001
181 BLOOD IRON DECREASED 1 0.0001
182 BACTERAEMIA 1 0.0001
183 MYOCLONUS 1 0.0001
184 PRESYNCOPE 2 0.0001
185 NEURALGIA 2 0.0001
186 ACCIDENTAL OVERDOSE 3 0.0001
187 INJECTION SITE URTICARIA 2 0.0001
188 SMALL INTESTINAL OBSTRUCTION 1 0.0001
189 INJECTION SITE EXTRAVASATION 1 0.0001
190 PRODUCT STORAGE ERROR 7 0.0001
191 MUSCLE ATROPHY 1 0.0001
192 HEPATIC CYTOLYSIS 1 0.0001
193 INFUSION SITE PAIN 1 0.0001
194 RASH GENERALISED 2 0.0001
195 SARS-COV-2 TEST POSITIVE 1 0.0001
196 EYE HAEMORRHAGE 1 0.0001
197 SINUS CONGESTION 1 0.0001
198 HAEMOPTYSIS 2 0.0001
199 APHONIA 1 0.0001
200 MASS 1 0.0001
201 BLOOD TEST ABNORMAL 1 0.0001
202 SKIN REACTION 1 0.0001
203 DIALYSIS 1 0.0001
204 INTENTIONAL DOSE OMISSION 2 0.0001
205 INCORRECT DOSE ADMINISTERED 16 0.0001
206 APATHY 1 0.0001
207 LABORATORY TEST ABNORMAL 2 0.0001
208 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
209 WEIGHT INCREASED 15 0.0001
210 BONE LOSS 1 0.0001
211 ECONOMIC PROBLEM 1 0.0001
212 BLOOD COUNT ABNORMAL 1 0.0001
213 HIP ARTHROPLASTY 1 0.0001
214 INJECTION SITE RASH 2 0.0001
215 PRURITUS 25 0.0001
216 MUSCULOSKELETAL CHEST PAIN 1 0.0001
217 BONE DENSITY DECREASED 2 0.0001
218 PRODUCT USE COMPLAINT 1 0.0001
219 ULCER 1 0.0001
220 IMPAIRED HEALING 2 0.0001
221 COAGULOPATHY 1 0.0001
222 EYE PRURITUS 2 0.0001
223 PRODUCT USE ISSUE 11 0.0001
224 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
225 RASH MACULAR 2 0.0001
226 EOSINOPHILIA 1 0.0001
227 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
228 BACTERIAL INFECTION 1 0.0001
229 BLOOD URINE PRESENT 1 0.0001
230 CHRONIC KIDNEY DISEASE 4 0.0001
231 INCREASED APPETITE 1 0.0001
232 LOWER LIMB FRACTURE 1 0.0001
233 PERIPHERAL SWELLING 8 0.0001
234 BLOOD PRESSURE ABNORMAL 1 0.0001
235 UPPER LIMB FRACTURE 1 0.0001
236 FEEDING DISORDER 1 0.0000
237 PYREXIA 17 0.0000
238 BODY TEMPERATURE INCREASED 1 0.0000
239 CHEST PAIN 9 0.0000
240 ILLNESS 5 0.0000
241 DERMATITIS 1 0.0000
242 HYPOAESTHESIA 7 0.0000
243 HYPOACUSIS 2 0.0000
244 POOR QUALITY SLEEP 1 0.0000
245 DEEP VEIN THROMBOSIS 3 0.0000
246 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
247 RASH MACULO-PAPULAR 1 0.0000
248 NEOPLASM MALIGNANT 3 0.0000
249 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
250 SNEEZING 1 0.0000
251 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
252 PARAESTHESIA 7 0.0000
253 DIARRHOEA 28 0.0000
254 DIZZINESS 21 0.0000
255 THERAPY INTERRUPTED 3 0.0000
256 RASH ERYTHEMATOUS 2 0.0000
257 URTICARIA 7 0.0000
258 BLOOD PRESSURE FLUCTUATION 1 0.0000
259 JOINT SWELLING 5 0.0000
260 LIVER INJURY 1 0.0000
261 ENCEPHALOPATHY 1 0.0000
262 PNEUMONIA 13 0.0000
263 PNEUMONIA ASPIRATION 1 0.0000
264 LEUKOPENIA 2 0.0000
265 COVID-19 7 0.0000
266 FLUID RETENTION 2 0.0000
267 THERAPY CESSATION 2 0.0000
268 FATIGUE 30 0.0000
269 ECZEMA 2 0.0000
270 ARTHRITIS 3 0.0000
271 JOINT STIFFNESS 1 0.0000
272 HYPERTENSION 8 0.0000
273 JAUNDICE 1 0.0000
274 LIMB INJURY 1 0.0000
275 MOOD ALTERED 1 0.0000
276 RESPIRATORY DISTRESS 1 0.0000
277 ANAPHYLACTIC REACTION 2 0.0000
278 MEDICATION ERROR 2 0.0000
279 INFLUENZA 4 0.0000
280 SEPSIS 4 0.0000
281 NECK PAIN 2 0.0000
282 COUGH 10 0.0000
283 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
284 MYALGIA 6 0.0000
285 MUSCULAR WEAKNESS 4 0.0000
286 ANGINA PECTORIS 1 0.0000
287 HYPERSOMNIA 1 0.0000
288 HERPES ZOSTER 2 0.0000
289 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
290 BALANCE DISORDER 3 0.0000
291 BACK PAIN 8 0.0000
292 OFF LABEL USE 30 0.0000
293 DYSPHONIA 2 0.0000
294 BONE PAIN 2 0.0000
295 CHILLS 4 0.0000
296 NASAL CONGESTION 2 0.0000
297 ABDOMINAL PAIN UPPER 7 0.0000
298 PAIN IN EXTREMITY 10 0.0000
299 ADVERSE DRUG REACTION 3 0.0000
300 DRUG INEFFECTIVE 44 0.0000
301 BLOOD POTASSIUM DECREASED 1 0.0000
302 APHASIA 1 0.0000
303 LACRIMATION INCREASED 1 0.0000
304 STOMATITIS 2 0.0000
305 NAUSEA 26 0.0000
306 EPILEPSY 1 0.0000
307 OROPHARYNGEAL PAIN 3 0.0000
308 SWELLING 3 0.0000
309 DYSPHAGIA 3 0.0000
310 METABOLIC ACIDOSIS 1 0.0000
311 DRUG INTOLERANCE 3 0.0000
312 NIGHT SWEATS 1 0.0000
313 PAIN 19 0.0000
314 SWELLING FACE 2 0.0000
315 STAPHYLOCOCCAL INFECTION 1 0.0000
316 VIRAL INFECTION 1 0.0000
317 SOMNOLENCE 6 0.0000
318 VOMITING 14 0.0000
319 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
320 FLUSHING 3 0.0000
321 CHEST DISCOMFORT 3 0.0000
322 INJECTION SITE REACTION 2 0.0000
323 DEATH 25 0.0000
324 DELIRIUM 1 0.0000
325 ABDOMINAL DISTENSION 3 0.0000
326 DYSPNOEA 16 0.0000
327 LYMPHADENOPATHY 1 0.0000
328 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
329 SKIN BURNING SENSATION 2 0.0000
330 HYPERGLYCAEMIA 1 0.0000
331 MUSCLE SPASMS 5 0.0000
332 HEADACHE 17 0.0000
333 DYSARTHRIA 1 0.0000
334 UNEVALUABLE EVENT 2 0.0000
335 COLITIS 1 0.0000
336 CONDITION AGGRAVATED 8 0.0000
337 MALAISE 11 0.0000
338 INJECTION SITE BRUISING 2 0.0000
339 PROSTATE CANCER 2 0.0000
340 EMOTIONAL DISTRESS 3 0.0000
341 EXTRA DOSE ADMINISTERED 1 0.0000
342 OEDEMA PERIPHERAL 3 0.0000
343 DYSKINESIA 1 0.0000
344 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
345 OSTEOPOROSIS 1 0.0000
346 CARDIAC ARREST 2 0.0000
347 ARTHRALGIA 10 0.0000
348 POLLAKIURIA 1 0.0000
349 ROAD TRAFFIC ACCIDENT 1 0.0000
350 SKIN EXFOLIATION 2 0.0000
351 OSTEOARTHRITIS 1 0.0000
352 VAGINAL HAEMORRHAGE 1 0.0000
353 SEPTIC SHOCK 1 0.0000
354 MENTAL DISORDER 1 0.0000
355 DEHYDRATION 3 0.0000
356 DRY SKIN 3 0.0000
357 THROAT IRRITATION 1 0.0000
358 VISION BLURRED 3 0.0000
359 HYPERSENSITIVITY 4 0.0000
360 ASTHENIA 8 0.0000
361 ARRHYTHMIA 1 0.0000
362 DISEASE RECURRENCE 1 0.0000
363 COMA 1 0.0000
364 MULTIPLE SCLEROSIS 1 0.0000
365 FEELING ABNORMAL 5 0.0000
366 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
367 HYPOGLYCAEMIA 1 0.0000
368 SYNCOPE 2 0.0000
369 CELLULITIS 1 0.0000
370 ACUTE KIDNEY INJURY 3 0.0000
371 INJECTION SITE PAIN 6 0.0000
372 INFLAMMATION 1 0.0000
373 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
374 NERVOUSNESS 1 0.0000
375 MUSCULOSKELETAL PAIN 1 0.0000
376 PANCREATITIS 1 0.0000
377 DRUG INTERACTION 3 0.0000
378 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
379 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
380 HAEMATOCHEZIA 1 0.0000
381 PANCYTOPENIA 1 0.0000
382 BLISTER 1 0.0000
383 CEREBROVASCULAR ACCIDENT 3 0.0000
384 DEPRESSION 4 0.0000
385 ANXIETY 5 0.0000
386 EYE IRRITATION 1 0.0000
387 MYOCARDIAL INFARCTION 3 0.0000
388 DISEASE PROGRESSION 2 0.0000
389 WHEEZING 1 0.0000
390 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
391 VERTIGO 1 0.0000
392 DISCOMFORT 1 0.0000
393 FEELING HOT 1 0.0000
394 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
395 VISUAL IMPAIRMENT 2 0.0000
396 BLOOD GLUCOSE INCREASED 3 0.0000
397 RHINORRHOEA 1 0.0000
398 RENAL FAILURE 2 0.0000
399 BLOOD PRESSURE DECREASED 1 0.0000
400 INJECTION SITE PRURITUS 1 0.0000
401 HEPATIC ENZYME INCREASED 1 0.0000
402 WEIGHT DECREASED 4 0.0000
403 BURNING SENSATION 1 0.0000
404 CONSTIPATION 3 0.0000
405 HALLUCINATION 1 0.0000
406 HOT FLUSH 1 0.0000
407 BLOOD PRESSURE INCREASED 2 0.0000
408 INJECTION SITE SWELLING 1 0.0000
409 DECREASED APPETITE 3 0.0000
410 ABDOMINAL PAIN 3 0.0000
411 INJECTION SITE HAEMORRHAGE 1 0.0000
412 THROMBOSIS 1 0.0000
413 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
414 FALL 4 0.0000
415 RENAL IMPAIRMENT 1 0.0000
416 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
417 MUSCULOSKELETAL STIFFNESS 1 0.0000
418 INSOMNIA 3 0.0000
419 TACHYCARDIA 1 0.0000
420 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
421 ADVERSE EVENT 1 0.0000
422 CARDIAC DISORDER 1 0.0000
423 PULMONARY EMBOLISM 1 0.0000
424 NEUROPATHY PERIPHERAL 1 0.0000
425 ANAEMIA 2 0.0000
426 MIGRAINE 1 0.0000
427 CONTUSION 1 0.0000
428 ALOPECIA 2 0.0000
429 HEART RATE INCREASED 1 0.0000
430 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
431 SINUSITIS 1 0.0000
432 HAEMOGLOBIN DECREASED 1 0.0000
433 ERYTHEMA 2 0.0000
434 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
435 HAEMORRHAGE 1 0.0000
436 THROMBOCYTOPENIA 1 0.0000
437 SEIZURE 1 0.0000
438 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
439 LOSS OF CONSCIOUSNESS 1 0.0000
440 HYPERHIDROSIS 1 0.0000
441 PSORIASIS 1 0.0000
442 NEUTROPENIA 1 0.0000
443 INFECTION 1 0.0000
444 CONFUSIONAL STATE 1 0.0000
445 ABDOMINAL DISCOMFORT 1 0.0000
446 NO ADVERSE EVENT 1 0.0000
447 NASOPHARYNGITIS 1 0.0000
448 GAIT DISTURBANCE 1 0.0000
449 HYPOTENSION 1 0.0000
450 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000